CVR number 30279689
Industry 86.2200 Specialist medical practice activities

OØR KLINIKKEN ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  2.6% 2.0% 3.9% 3.6% 1.2%  
Credit score (0-100)  63 69 49 52 80  
Credit rating  BBB A BBB BBB A  
Credit limit (kDKK)  0.0 0.3 0.0 0.0 106.3  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  2,378 2,449 3,017 3,989 3,710  
Gross profit  2,138 2,206 2,878 3,851 3,542  
EBITDA  903 887 1,392 2,352 2,064  
EBIT  835 837 1,390 2,352 1,814  
Pre-tax profit (PTP)  797.2 1,480.9 1,259.0 2,523.8 2,337.2  
Net earnings  632.0 1,173.6 1,017.0 1,948.8 1,848.5  
Pre-tax profit without non-rec. items  797 1,481 1,259 2,524 2,337  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  202 152 0.0 0.0 997  
Shareholders equity total  440 1,132 1,494 2,618 4,151  
Interest-bearing liabilities  1,054 1,534 24.0 36.0 36.0  
Balance sheet total (assets)  1,982 3,197 1,943 3,418 5,388  
Net Debt  1,054 1,390 -444 -1,008 -347  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  2,378 2,449 3,017 3,989 3,710  
Net sales growth  -0.1% 3.0% 23.2% 32.2% -7.0%  
Gross profit  2,138 2,206 2,878 3,851 3,542  
Gross profit growth  -2.7% 3.2% 30.5% 33.8% -8.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,982 3,197 1,943 3,418 5,388  
Balance sheet change%  35.7% 61.3% -39.2% 76.0% 57.6%  
Added value  902.6 887.1 1,391.9 2,354.3 2,063.6  
Added value %  38.0% 36.2% 46.1% 59.0% 55.6%  
Investments  135 -101 -154 0 748  
Net sales trend  -1.0 1.0 2.0 3.0 -1.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  38.0% 36.2% 46.1% 59.0% 55.6%  
EBIT %  35.1% 34.2% 46.1% 59.0% 48.9%  
EBIT to gross profit (%)  39.1% 37.9% 48.3% 61.1% 51.2%  
Net Earnings %  26.6% 47.9% 33.7% 48.9% 49.8%  
Profit before depreciation and extraordinary items %  29.4% 50.0% 33.8% 48.9% 56.5%  
Pre tax profit less extraordinaries %  33.5% 60.5% 41.7% 63.3% 63.0%  
ROA %  56.6% 59.2% 74.3% 100.0% 48.8%  
ROI %  68.0% 73.7% 61.2% 121.8% 69.5%  
ROE %  197.9% 149.3% 77.4% 94.8% 54.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  22.2% 35.4% 76.9% 76.6% 77.0%  
Relative indebtedness %  64.8% 84.3% 14.9% 20.1% 33.3%  
Relative net indebtedness %  64.8% 78.4% -0.6% -6.1% 23.0%  
Net int. bear. debt to EBITDA, %  116.7% 156.7% -31.9% -42.8% -16.8%  
Gearing %  239.4% 135.4% 1.6% 1.4% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  2.8% 4.0% 1.8% 10.7% 111.4%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.5 1.9 3.8 1.2  
Current Ratio  0.3 0.5 1.9 3.8 1.2  
Cash and cash equivalent  0.0 143.5 467.8 1,043.9 383.1  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  4.2% 5.9% 15.5% 26.2% 10.3%  
Net working capital  -252.5 -130.0 226.1 771.9 60.8  
Net working capital %  -10.6% -5.3% 7.5% 19.4% 1.6%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0